Patients with vitamin D deficiency are three times more likely to experience moderate-to-severe pain following mastectomy surgery [1].

This finding suggests that preoperative nutritional status may play a critical role in managing postoperative recovery and reducing the reliance on potent painkillers for cancer patients.

Researchers said vitamin D deficiency is associated with an increase in moderate-to-severe pain and a higher consumption of opioid drugs [2]. The study indicates that those lacking the vitamin faced a three-fold increase in the likelihood of severe pain compared to those with sufficient levels [1].

Researchers said, "Patients deficient in vitamin D were three times more likely to experience moderate to severe pain after mastectomy surgery" [1]. This correlation points to a potential gap in standard preoperative care that could be addressed through screening and supplementation.

Scientists believe the vitamin may help regulate how the body processes pain. They said this happens through the effects of vitamin D on the immune system, and inflammation [1]. By modulating these biological responses, the vitamin may mitigate the intensity of the pain felt after a surgical procedure.

Researchers also said that vitamin D deficiency is associated with more moderate to severe pain following breast cancer surgery and an increased consumption of opioid drugs [2]. The link between low vitamin D levels and increased opioid use highlights a potential pathway to reduce dependency on narcotics during the recovery phase.

While the study establishes a strong link, researchers continue to investigate the precise mechanisms of how vitamin D interacts with pain receptors. Addressing this deficiency before surgery could potentially change the postoperative experience for thousands of patients each year [1].

“Patients deficient in vitamin D were three times more likely to experience moderate to severe pain after mastectomy surgery.”

This research suggests that vitamin D levels could serve as a biological marker for predicting postoperative pain. If validated in wider clinical practice, it may lead to mandatory vitamin D screening and supplementation protocols prior to mastectomy to improve patient outcomes and lower the risks associated with high-dose opioid prescriptions.